Pivotal Phase III BouNDless Trial for Parkinson’s Disease Patients with Motor Fluctuations
Ryan Case, PhD, Head of Clinical Medical Affairs at Neuroderm, a Mitsubishi Tanabe Pharma Corporation (MTPC), discusses the highly positive results from...
819 articles
Ryan Case, PhD, Head of Clinical Medical Affairs at Neuroderm, a Mitsubishi Tanabe Pharma Corporation (MTPC), discusses the highly positive results from...
Lisa Yañez, CEO of Aerami Therapeutics, a clinical-stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulm...
Antonio Anzueto, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the Univ...
Robert Risinger, Chief Medical Officer, Neuroscience at BioXcel Therapeutics, a biopharmaceutical company that uses artificial intelligence (AI) to iden...
Cardiologists at Northwestern Medicine are using AI to identify patients with advanced heart failure who require specialized care, including those who m...
Juliet Knowles, MD, PhD, pediatric neurologist at Stanford Medicine Children’s Health and assistant professor of Neurology and of Pediatrics at Stanfo...
Mike Krams, Chief Quantitative Medicine Officer at Exscientia plc discusses the first clinical trial application (CTA) approval in ...
Metastatic breast cancer or mBC, also known as stage 4, cannot be cured and therefore brings a different experience than earlier stage cancer.
MeiLan Han, MD, MS, Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan discusses chronic obstr...
Many service members who deployed to Iraq and Afghanistan following 9/11 are left struggling today with debilitating lung and respiratory conditions.